Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|July 31, 2023
Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn's diseaseRajat Garg, Manik Aggarwal, Abdul Mohammed, et al.Journal of Cancer|October 20, 2023
The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic ReviewAntonio Pizuorno Machado, Hunter Ratliff, Ahmed Abdelwahab, et al.Journal of Cancer|October 2, 2023
Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated ColitisAntonio Pizuorno Machado, Malek Shatila, Enrico N De Toni, et al.Journal of Cancer|July 21, 2023
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with CancerCynthia Liu, Malek Shatila, Antony Mathew, et al.Journal of Crohn'S & Colitis|January 3, 2021
Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic ResectionRavi S Shah, Salam Bachour, Xue Jia, et al.Annals of Gastroenterology|March 23, 2026
Isolated immune-mediated enteritis in patients treated with immune checkpoint inhibitor therapySharada Wali, Rohan Srinivas Patel, Maria Julia Moura Nascimento Santos, et al.Journal of Crohn'S & Colitis|June 15, 2022
Intra-abdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn's disease recurrenceSalam P Bachour, Ravi S Shah, Florian Rieder, et al.Alimentary Pharmacology & Therapeutics|March 14, 2022
Mild neoterminal ileal post-operative recurrence of Crohn's disease conveys higher risk for severe endoscopic disease progression than isolated anastomotic lesionsSalam P Bachour, Ravi S Shah, Ruishen Lyu, et al.Inflammatory Bowel Diseases|June 6, 2024
Postoperative Crohn's Disease Recurrence Risk and Optimal Biologic Timing After Temporary Diversion Following Ileocolic ResectionAbel Joseph, Salam P Bachour, Ravi Shah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated ColitisHamzah Abu-Sbeih, Faisal S Ali, Abdul Rafeh Naqash, et al.Pageof 3